On this page
Craniosynostosis (Muenke)
Muenke syndrome affects the development of the skull and face, leading to distinctive features. It is caused by changes in the FGFR3 gene and is inherited in an autosomal dominant pattern. This condition typically involves the premature closure of one or both coronal sutures.
Available at Jeen Health
Clinical tests that include this
Overview
Muenke syndrome is a genetic disorder identified by craniosynostosis, which is the premature fusion of one or more skull sutures. These sutures are fibrous joints that allow the skull to grow as the brain develops. In Muenke syndrome, the coronal sutures, located along the top sides of the head, are most commonly affected, either on one side (unilateral) or both sides (bilateral) [PMID:12483864]. If these sutures close too early, the skull cannot expand normally, which can lead to an unusual head shape and may sometimes affect brain development or increase pressure within the skull.
Estimates suggest Muenke syndrome occurs in approximately 1 in 30,000 live births. It is considered one of the more common forms of syndromic craniosynostosis. The condition can show variable features, meaning that even within the same family, individuals with the same genetic change may experience different severities or combinations of symptoms.
Symptoms & clinical features
The primary symptom of Muenke syndrome is craniosynostosis, most often affecting the coronal sutures. When both coronal sutures fuse prematurely, it can result in a head shape known as brachycephaly, where the head appears tall and broad with a flattened forehead. If only one coronal suture is affected, it can lead to plagiocephaly, causing an asymmetrical head shape. The premature fusion can also sometimes be associated with a widened space between the eyes (hypertelorism) and a flattened midface [PMID:11130620].
Beyond cranial features, individuals with Muenke syndrome may also have hearing loss, which can range from mild to moderate and is often conductive. They might also experience carpal tunnel syndrome and, less frequently, problems with the bones of the spine or feet. Developmental delays can occur in some individuals, particularly if high intracranial pressure is present, although intellectual disability is not a consistent feature [PMID:10077651].
Video: Genetics 101
Affected organs
Muenke syndrome primarily affects the skeletal system, particularly the bones of the skull and face. The premature fusion of skull sutures directly impacts cranial shape and can affect the brain's development within the restricted space. Facial bones may also develop unusually, leading to characteristic features such as hypertelorism and midfacial hypoplasia (underdevelopment of the middle part of the face).
Other body systems that can be affected include the auditory system, potentially causing conductive hearing loss due to structural issues in the middle ear. Less commonly, skeletal abnormalities might also be observed in the hands, such as carpal tunnel syndrome, and in the feet or spine. The brain itself can be indirectly affected if craniosynostosis leads to increased intracranial pressure.
Risks & severity
The severity of Muenke syndrome can vary significantly among affected individuals, even within the same family. Some people might have only mild skull changes that require minimal intervention, while others may experience more extensive craniosynostosis needing multiple surgeries. The primary risks are related to the premature closure of the skull sutures. If left unmanaged, severe craniosynostosis can lead to increased pressure on the brain (intracranial pressure), which may impair cognitive development, vision, or cause headaches.
While most individuals with Muenke syndrome have typical intelligence, developmental delays or intellectual disability can occur, especially in cases with severe cranial involvement and prolonged elevated intracranial pressure. Hearing loss is a common risk, affecting a substantial proportion of individuals. The age of onset for features such as craniosynostosis is typically at birth or during early infancy, as this is when skull development is most rapid. Carpal tunnel syndrome may present later in childhood or adulthood.
Genetic causes
Muenke syndrome is caused by a specific genetic change in the FGFR3 gene. This gene provides instructions for making the fibroblast growth factor receptor 3 protein. This protein plays a crucial role in regulating cell growth and division, particularly important for the proper development of bones and cartilage.
When a specific pathogenic variant occurs in FGFR3, it leads to an overactive FGFR3 protein. This overactivity disrupts the normal signalling pathways that control bone growth, causing cartilage cells in the skull sutures to mature and fuse prematurely. The most common genetic change associated with Muenke syndrome is a specific alteration at position 755 in the FGFR3 gene, denoted as p.Pro250Arg [PMID:11130620]. This alteration is responsible for almost all cases of the syndrome.
- FGFR3 fibroblast growth factor receptor 3The FGFR3 gene provides instructions for making fibroblast growth factor receptor 3, a protein crucial for regulating cell growth, differentiation, and especially skeletal development.
Inheritance pattern
Muenke syndrome is inherited in an autosomal dominant pattern. This means that an individual only needs one copy of the altered FGFR3 gene to develop the condition. If a parent has Muenke syndrome, there is a 50% chance with each pregnancy that their child will also inherit the altered gene and develop the syndrome. The condition affects males and females equally.
the features and severity of Muenke syndrome can be very variable, even among family members who share the same genetic change. This is known as variable expressivity. Spontaneous new (de novo) genetic changes can also occur in individuals with no family history of the condition, meaning the genetic change happens for the first time in that individual.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Muenke syndrome is often suspected based on characteristic clinical findings, such as the specific pattern of craniosynostosis and facial features during a physical examination shortly after birth or in early infancy. Imaging studies, such as X-rays, CT scans, or MRI, can confirm the presence and extent of craniosynostosis.
Definitive diagnosis is established through genetic testing of the FGFR3 gene. This testing typically involves molecular genetic analysis to identify the specific p.Pro250Arg variant or other rare pathogenic changes in FGFR3. In the UK, genetic testing for craniosynostosis syndromes falls under the NHS Genomic Medicine Service (GMS) pathways. Referrals for genetic testing and counselling are usually made by paediatricians, craniofacial specialists, or clinical geneticists, aligning with relevant NHS R-codes for syndromic craniosynostosis.
Management & lifestyle
Management for Muenke syndrome is multidisciplinary and individualised, focusing on addressing the specific symptoms and potential complications. Surgical correction of craniosynostosis is often required to reshape the skull, relieve pressure on the brain, and improve facial symmetry. The timing and type of surgery depend on the number and location of fused sutures, and the child's age and overall health.
Ongoing care involves regular monitoring for potential issues such as increased intracranial pressure, hearing impairment, and developmental progress. Regular audiology assessments are recommended due to the risk of hearing loss. Developmental support and therapy may be beneficial for any developmental delays. Genetic counselling is an important part of management, providing information about the condition, inheritance patterns, and reproductive options for affected individuals and their families. Management aligns with NHS care pathways for complex craniofacial conditions, typically involving specialist craniofacial units.
UK care pathway
In the UK, individuals suspected of having Muenke syndrome are typically referred through general practitioners or paediatricians to specialist NHS services. This often involves clinical genetics teams, who can provide expert assessment, genetic counselling, and arrange for appropriate genetic testing (which falls under the NHS Genomic Medicine Service). These services follow specific R-codes for genetic testing, ensuring standardised care. Patients may also be referred to regional craniofacial units, which provide multidisciplinary care for complex craniofacial conditions, including surgical planning and ongoing management. Genetic counsellors play a vital role in explaining the genetic basis of the condition and its implications for the family.
Frequently asked questions
What is the likelihood my child will inherit Muenke syndrome if I have it?
Because Muenke syndrome is inherited in an autosomal dominant pattern, there is a 50% chance with each pregnancy that your child will inherit the altered FGFR3 gene and develop the condition. This probability remains the same for every child you have.
Will my child need surgery for Muenke syndrome?
Many children with Muenke syndrome typically require surgery to correct the prematurely fused skull sutures. The need for surgery, its timing, and the specific procedure will depend on the severity of the craniosynostosis and its impact on your child's head shape and brain development. This will be discussed by a specialist craniofacial team.
Is Muenke syndrome always associated with learning difficulties?
No, most individuals with Muenke syndrome have typical intelligence. However, developmental delays can occur in some cases, particularly if the craniosynostosis leads to increased pressure on the brain that is not managed. Regular developmental assessments are part of ongoing care.
Can Muenke syndrome affect hearing?
Yes, hearing loss is a common feature associated with Muenke syndrome. It is often conductive hearing loss, meaning there is a problem with how sound waves are transmitted through the outer or middle ear. Regular hearing tests are recommended to monitor for this.
How is Muenke syndrome diagnosed?
Muenke syndrome is typically diagnosed based on physical examination findings and confirmed through genetic testing, which looks for specific changes in the FGFR3 gene. Imaging tests like CT scans may also be used to assess the skull sutures. In the UK, diagnosis follows NHS Genomic Medicine Service pathways involving clinical genetics teams.